Original Article intrOductiOn For many years, 131 I has played a central role in evaluating thyroid diseases and has an established role in the follow-up and management of differentiated thyroid carcinoma (DTC). Although DTC have a good prognosis, the main metastatic pattern is lymph nodal (LN) metastasis. It has been reported that up to 36% of cases of papillary thyroid carcinoma and 17% of cases of follicular thyroid carcinoma are accompanied with cervical LN metastasis [1] and nodal metastasis is strongly related to higher incidence of recurrence.
radioiodine and FDG avid lesions depending on varying grades of differentiation among various lesions. Poorly differentiated or progressively dedifferentiated thyroid cancer do not express NIS gene and thereby exhibit negative WBI scan indicating a grave prognosis. These are usually refractory to high-dose 131 I therapy and may need advanced redifferentiation therapies and tyrosine kinase inhibitors. Feine et al. have shown that there can be a flip-flop in scan uptake patterns in thyroid cancers, first being 131 I positive, FDG negative, and with disease progression and dedifferentiation becoming FDG positive, iodine negative. [6] It is these latter tumors, those that are iodine negative, in which FDG PET appears to be most potentially beneficial. Here, we illustrate rare sites of solitary 131 I concentrating distant metastases and a few sites of benign 131 I uptake.
MateriaLS and MethOdS
We retrospectively analyzed 13,000 patients who underwent WBI in the Nuclear Medicine Department of Amrita Institute of Medical Sciences, Cochin from 2007 onwards. Lymph nodes, lungs, and bones are the common sites of distant metastases in DTC that can be managed palliatively with multiple doses of high-dose 131 I therapy. In this pictorial review, a range of rare 131 I concentrating DTC metastatic deposits in sella, orbit, choroid, skeletal muscles, liver, skin, costochondral soft tissue, pancreas and kidney, and a few benign 131 I concentrating sites are being illustrated. A few of these patients also underwent whole body FDG PET/CT imaging as part of their workup which is also being depicted here.
Brain metastasis
A 49-year-old male, diagnosed case of follicular carcinoma of thyroid and cervical lymph nodal metastases, underwent total thyroidectomy. Patient received high-dose 131 I therapy on three occasions with a cumulative dosage of 349 mCi. Later he developed recurrent headache and progressively worsening double vision for 2 weeks [ Figure 1 ]. Follow-up WBI scan showed no abnormal 131 I uptake in anterior neck, sella region, or elsewhere but stimulated Tg was elevated (167 ng/ml, normal is <2 ng/ml). Patient was thus categorised as a case of TENIS syndrome. Brain magnetic resonance imaging (MRI) T1 contrast coronal image showed an enhancing metastatic deposit in sella with suprasellar extension. Solitary brain metastases from DTC are extremely rare i.e. approximately 1% of all DTC. It typically affects older patients with aggressive thyroid cancer, with a reported incidence of 0.15-1.3%. [4] The reported median survival of patients diagnosed with brain metastasis varies between 4 months to 33 months. [4] Because of its rarity, the impact of brain metastasis on the survival of patients with DTC is unknown, and there are no clear guidelines for their management. For brain metastasis in general, although treatment guidelines can differ based on the prognosis of the patients and its extent, surgery remains the preferred treatment modality. [7] Brain metastasis is associated with very poor prognosis even with combined treatment using high-dose 131 I therapy, external radiotherapy, and chemotherapy. treatment in DTC which is followed by diagnostic whole body 131 I (WBI) scan. Patients undergoing 131 I diagnostic scan or high-dose 131 I ablation/metastatic therapy are weaned off (for 3-4 weeks) stable iodine-containing foods such as seafood, iodised salt, drugs (cough expectorants, povidone iodine, amiodarone), and iodinated contrast agents 3-6 months prior to the procedure. It is mandatory to stop tablet thyroxine for 3-4 weeks prior to 131 I imaging or therapy so as to increase the endogenous thyroid stimulating hormone (TSH) level >30 µIU/ml (micro International unit/milliliter). These salient instructions facilitate the uptake of 131 I by thyrocytes so that a higher therapeutic benefit is derived by the patient. Diagnostic WBI scan is usually performed 48-72 h after oral radioiodine administration using high-energy collimators on a Gamma camera. Radioiodine concentration in normal and affected thyrocytes is based on sodium iodide symporter (NIS) uptake mechanism. NIS is known to exist and has an active role also in other tissues as shown in Table 1 . Many organs including the liver do not exhibit the NIS expression.
The role of 18-Flurodeoxyglucose positron emission computed tomography-computed tomography (18F FDG PET/CT) in thyroid cancer remains in evolution. There is no role for FDG PET/CT in the initial evaluation of DTC. However, FDG PET/CT is a well-established imaging modality in the evaluation of patients with TENIS syndrome (thyroglobulin elevated negative iodine scan) to look for occult disease. The use of FDG PET/CT in the initial staging and response evaluation of aggressive and poorly DTCs is also well known.
Prognosis of
131 I negative DTC metastasis (TENIS), the so-called non-functioning metastasis (I 131 non concentrating), is significantly worse. In these patients, an early diagnosis of non-functioning metastasis and their surgical extirpation remains to be the optimal therapeutic approach. At this stage there is an activation of cellular glucose metabolism, enabling FDG uptake in these dedifferentiated cells. By virtue of their increased growth rate and subsequent increased utilization of glucose, these lesions then become detectable by the FDG PET/CT imaging.
This pattern of differential radiotracer (
131 I negative but FDG positive) uptake is called ''flip-flop phenomenon.'' The WBI and the FDG PET/CT scans are, therefore, complementary in this clinical scenario. Most often, a lesion will take up either only radioiodine or FDG, although a patient can have both the 
Ocular (uveal) metastasis
A 56-year-old male with metastatic papillary carcinoma of thyroid s/p total thyroidectomy was referred for WBI scan. Scan showed extensive 131 I concentrating skeletal metastases. He was treated twice with high-dose 131 I therapy [ Figure 2a ]. Follow-up WBI scan after second dose showed abnormal focal 131 I uptake corresponding to lesion in right orbit. After 2 weeks, patient developed sudden onset of diminished vision on the right side. Ophthalmic examination was performed [ Figure 2b ]. Ultrasound B scan showed two choriodal mass lesions in lower and posterior quadrants with homogenous internal opacity. Scan confirmed associated posterior uveal (choroidal) metastases on the right side. An urgent ophthalmic examination revealed a visual acuity of 6/24 of the right eye with right relative afferent papillary defect and choroidal lesions causing exudative retinal detachment on the right side. Ocular metastases secondary to thyroid cancer are extremely uncommon, typically affecting the orbit rather than the globe and uvea. Within the uveal structures, the choroid is more commonly involved than the iris and ciliary body. The literature review [8, 9] shows that posterior uvea (choroid) is most commonly involved (88%), followed by anterior uvea [i.e., iris (9%) and ciliary body (2%)].
Orbital metastases
A 58-year-old male with histologically proven papillary thyroid cancer s/p total thyroidectomy underwent high-dose 131 I residual thyroid ablation. Patient later presented with swelling close to lateral aspect of the right eye. MRI of orbit showed enhancing soft tissue mass measuring 3.2 × 2 cm along the superolateral aspect of right orbit, abutting lateral rectus 
Breast metastasis
A 47-year-old woman with multifocal papillary thyroid carcinoma, underwent total thyroidectomy. WBI scan was performed and patient was orally ablated with 70 mCi of 131 I sodium iodide solution. Post-therapy WBI scan showed a focal site of abnormal 131 I uptake in the right lower chest [ Figure 4 ]. SPECT-CT thorax localized the lesion a b a b
Figure 4:
A 47-year-old woman with multifocal papillary thyroid carcinoma, underwent total thyroidectomy and high-dose 131 I residual thyroid ablation. Post-therapy WBI scan showed a focal site of abnormal 131 I uptake in the right lower chest (Arrow indicating I 131 uptake in right breast lesion). SPECT-CT thorax localized the lesion to lower outer quadrant of right mammary gland raising the suspicion of a co-existing primary breast malignancy or a metastastic deposit from DTC. Ultrasound guided FNAC confirmed breast lesion to be metastases from DTC
Figure 3:
A 58-year-old male with papillary thyroid cancer s/p total thyroidectomy and high-dose 131 I residual thyroid ablation with the right eye swelling. MRI of orbit was done which showed enhancing soft tissue mass measuring 3.2 × 2 cm along the superolateral aspect of right orbit. WBI scan showed functioning metastases at superolateral aspect of right orbit (Arrow depicting lesion). SPECTCT showed lesion abutting the lateral rectus muscle and lacrimal gland, displacing the globe medially. Stimulated Tg was 1670 ng/ml to lower outer quadrant of right mammary gland raising the suspicion of a co-existing primary breast malignancy or a metastastic deposit from DTC. An ultrasound-guided fine-needle aspiration cytology (FNAC) confirmed metastases from DTC. Isolated breast metastasis from DTC are extremely rare.
131 I uptake in both lactating and non-lactating breasts has been described. In the lactating breast, as well as in the thyroid gland, NIS mediates iodine uptake. [10] Radioiodine uptake in benign breast pathologies can be seen with gynecomastia, supernumerary breasts, and lactational duct cyst or galactocele. Increased 131 I uptake is also associated with hyperprolactinemia. [11] To date, only 11 cases of breast metastases arising from DTC have been described in the literature, but these are invariably associated with other sites of DTC metastasis.
Cutaneous metastasis
A 45-year-old male presented with multinodular goiter. FNAC from thyroid was reported as a follicular neoplasm. He underwent total thyroidectomy and right neck dissection. Histopathology revealed a papillary thyroid carcinoma -conventional type (pT3N1bMx). WBI scan showed 131 I concentrating residual thyroid tissue with suspicious cervical nodal metastases. Patient was ablated with 120 mCi of 131 I orally. Four months later patient developed small painless, purple-colored skin nodules [ Figure 5 ]. Tg while on T4 was found to be elevated. Whole body FDG PET/CT off T4 for 3 weeks (TSH >30 uIU/ml) was suggested. Images showed focal FDG avidity in multiple intramuscular deposits (left 6 th intercostal space, left gluteus intermedius, paravertebral muscle on left side at level of L4/L5, right pectoralis major anterior to 3 rd rib, right psoas muscle, left longissimus colli, and bilateral latissmus dorsi). Stimulated Tg was also performed which was significantly elevated (845 ng/ml). Cutaneous and intramuscular nodules cytopathology was positive for metastatic papillary thyroid carcinoma. In view of extensive cutaneous and intramuscular nodular metastases, patient was treated with 170 mCi of 131 I. On review, patient had further deterioration of the disease clinically and based on the thyroid tumor board decision, patient was started on tyrosine kinase inhibitors. Presentation of cutaneous metastases is associated with advanced disease. Dahl et al. [12] reported that papillary thyroid carcinoma was most common (41%) followed by follicular (28%), anaplastic (15%), and medullary carcinomas (15%), respectively. The scalp was the most common site of metastasis in that series.
Liver metastasis
A 40-year-old man, with papillary carcinoma of thyroid with cervical lymph nodal metastases post-total thyroidectomy, central compartmental neck dissection, and radioiodine ablation, presented to our department with rising Tg. Follow-up WBI scan was negative. He was orally ablated with 184 mCi of 131 I [ Figure 6 ]. Post-131 I therapy WB scan showed a solitary functioning right lobe of liver metastasis (confirmed with SPECT-CT) and histopathology. Liver metastasis from DTC is a rare event, with a reported frequency of 0.5%. [13] Only 10 cases have been documented in the literature so far.
Pancreas and kidney metastases
A 60-year-old female patient with follicular carcinoma of thyroid and lymph nodal metastases underwent total thyroidectomy. About 3 weeks later WBI scan was done which was negative [ Figure 7a ]. Stimulated Tg was >1000 ng/ml with TSH of only 1.2 uIU/ml. Recombinant human TSH (rhTSH) assisted whole body FDG PET/CT was performed (TSH >100 uIU/ I. Clinical detection of DTC metastasis of the kidney is infrequent. [14] Both the kidney and pancreatic involvement are unusual and extremely rare without any nodal or other sites of distant metastases. To the best of our knowledge, only 25 cases have been reported in the literature.
Muscle (deltoid) metastasis
A 66-year-old male, a case of multinodular goiter underwent total thyroidectomy. Histopathology revealed completely intrathyroidal widely invasive follicular thyroid carcinoma (3.3 × 2.5 × 2 cm) in the left upper lobe with micropapillary carcinoma in the right lobe. Diagnostic WBI scan was done and patient was treated with 70 mCi of 131 I [ Figure 8a ]. Six months later WBI scan showed no abnormal 131 I uptake in anterior neck and rest of whole body but stimulated Tg was high (124 ng/ml). Whole body FDG PET/CT (non-contrast study) was suggested to look for any occult site of metastases. Figure 8b 18-F FDG PET/CT showed no local recurrence but an isolated FDG avid lesion in left deltoid muscle suggestive of a metastatic deposit. Ultrasound examination of the lesion showed an echogenic nodule measuring 12.8 mm in the deltoid muscle anteriorly. Excision biopsy revealed a neoplasm of follicular and papillary patterns amidst skeletal muscle fibers with nuclear clearing and many intranuclear pseudoinclusions. Neoplasm showed diffuse positivity for cytokeratin 19 (CK19), TTF-1, and Tg on immunohistochemistry (IHC). The literature review shows that hematogenous metastasis from DTC to skeletal muscle is extremely rare. [15] A retrospective review of the literature revealed only 10 reports of DTC muscle metastases. Although occasionally soft tissue metastases may present themselves as painful masses, they are usually asymptomatic. Therefore, they may be an unexpected finding in imaging studies. Besides the possibility of underdiagnosis, several factors have been implicated in the rare occurrence of soft tissue metastases, such as muscle motion, mechanical tumor destruction, muscle ability to remove tumor-produced lactic acid, changes in pH, accumulation of metabolites, and local temperature of the soft tissue sites. In addition, blood flow is variable, influenced by adrenergic receptors, and subject to variations in tissue pressure affecting cancer implantation.
Costochondral and soft tissue metastases
Whether traumatic injury to soft tissue is a risk factor for soft tissue metastases remains undetermined.
Solitary bone metastases
Sacral metastases -A 68-year-old male with papillary Ca thyroid s/p completion thyroidectomy operated in 1999. A 60-year-old female patient with follicular carcinoma of thyroid with lymph nodal metastases underwent total thyroidectomy. Three weeks later (a) WBI scan was done which was negative stimulated serum thyroglobulin was >1000 ng/ml with TSH of only 1.2 uIU/ml. Recombinant human TSH (rhTSH) assisted whole body FDG PET/CT was performed (TSH was >100 uIU/ml after two intramuscular rhTSH injections). Images showed FDG avid metastatic deposits in the pancreas (b), and the right kidney (c) Cross hair shows FDG avid pancreatic and renal metastatic deposit Figure 12 ] -A 56-year-old lady presented with goiter. She was investigated and underwent total thyroidectomy with central compartmental neck dissection. Histopathology suggested papillary thyroid carcinoma with lymph nodal metastases. WBI scan revealed minimal residual thyroid tissue with left lower cervical nodal metastases and unsuspected 131 I concentrating right scapular deposit. As stimulated Tg was 659 ng/ml, whole body FDG PET/CT was suggested. PET/CT confirmed FDG avid left thyroid bed lesion, highest mediastinal nodal and right scapular metastatic deposit.
Scapular deposit [
Bone metastases represent a frequent complication especially of follicular thyroid cancer. Palliative treatment is frequently the only option at diagnosis. These osteolytic lesions reduce severely the quality of life causing pain, fractures, and spinal cord compression. More than 80% of bone metastases from all tumors including DTC are located in axial skeleton red marrow where blood flow is high (vertebrae, ribs, and hips). Surgical option is preferred wherever feasible. Higher dose of 131 I (150-200 mCi) is recommended in presence of skeletal metastatic deposits. Patients usually need multiple doses of high-dose 131 I therapy. External radiotherapy is also indicated in these cases.
Benign sites of I 131 uptake
Benign causes of 131 I have been encountered in day-to-day practice. False-positive radioiodine uptake can be classified according to the underlying mechanism as follows; (1) External contamination (skin, hair, garment). The uptake in soft tissues has been reported at the following sites and disease conditions; in fat necrosis of the breast, [16] lactating breasts, patient on hormonal therapy, or oral contraceptive pills (Figure 13 thick arrow) . Patients display false positive I131 uptake in tracheostomy, inflamed cysts like ovarian/ lymphoepithelial cyst, skin burns, skin wound, and even in a psoriatic plaque. Iodine uptake in rib may be due to benign causes also. Iodine uptake in the pleura and mediastinum has also been described in pleuropericardial cyst, saliva and esophageal-retained saliva (thin arrow Figure 13 ), Barrets esophagus, Zenker's diverticulum, and sites of ectopic thyroid tissue, can also produce false-positive scans with radioiodine. Benign 131 I uptake has been reported in pericardial effusion and myocardial infarction. It is also seen in infective and inflammatory lung diseases. Inflamed tissues undergo certain biological events like increased blood flow and capillary permeability. Increased permeability can result in an abundance of cells in tissue or vessels, and stasis of radio-iodinated blood can also occur due to an increase in the concentration of cells within blood. All these lead to false-positive WBI scan. Tg estimation serves as a robust tumor marker to identify any such benign cause of 131 I uptake from a malignant thyroid deposit.
Retroverted uterus/ovarian neoplasm or cysts
Retroverted uterus: A premenopausal patient with papillary Ca thyroid underwent total thyroidectomy for goiter. WBI scan showed moderate to significant residual thyroid tissue with focal 131 I uptake in pelvis. SPECT-CT localized this focus to retroverted uterus [ Figure 14 ]. No obvious lesion was seen on CT pelvis. The 131 I uptake in this case is most likely physiological in uterus being a vascular organ.
Ovarian etiology: Two cases of papillary Ca thyroid, post-total thyroidectomy are being described. A case of papillary Ca thyroid [ Figure 15a ], post-thyroidectomy shows focal 131 I uptake in left upper cervical nodal metastases on WBI scan. An additional site of focal 131 I uptake is revealed intrapelvically. SPECT-CT of pelvis localized the uptake to ovary raising a suspicion of left ovarian pathology. Further investigation with ultrasound and CT confirmed inflamed corpus luteal cyst. Another case [ Figure 15b ] of DTC depicting 131 I uptake in bilateral ovaries, confirmed on further investigation to be bilateral ovarian teratomas. Teratomas are slow-growing tumors that contain elements from multiple germ cell layers and are best assessed with ultrasound. They usually occur in young women 20-30 years of age. Uncomplicated ovarian teratomas tend to be asymptomatic and are often discovered incidentally. Mature cystic teratomas are encapsulated tumors with mature tissue or organ components. They are composed of well-differentiated derivatives from at least two of the three germ cell layers (i.e., ectoderm, mesoderm, and endoderm). They, therefore, contain developmentally mature skin complete with hair follicles and sweat glands, sometimes with luxuriant clumps of long hair, and often pockets of sebum, blood, fat, bone, nails, teeth, eyes, cartilage, and thyroid tissue. They can be bilateral in 10-15% cases. Being slow-growing tumors, a non-surgical conservative management is generally implemented.
Ovarian cysts are fluid-filled sacs which are usually asymptomatic. Most ovarian cysts are related to ovulatory cycles, being either follicular or corpus luteal cysts. Other types include cysts due to endometriosis and cystadenomas apart from teratomas. Pelvic inflammatory disease and polycystic ovarian disease can also result in ovarian cysts.
Other cystic structures known to show false-positive findings on radioiodine, include nasolacrimal sac, pleuropericardial, bronchogenic, thymic, breast, hepatic, renal, ovarian, epithelial, and sebaceous cysts. Entry of radioiodine into cysts occurs via passive diffusion or partially active transport. Due to the slow exchange of water and chemical elements between the cysts and their surrounding extracellular/extravascular environment, radioiodine gets trapped within the cysts [17] producing false-positive scans. Inflammation and infection attribute a major chunk of false-positive 131 I uptake sites. It is thought that leukocytes stimulate the formation of inflammatory exudates in chronic inflammatory processes. It alters blood vessels to permit migration of leukocytes outside of the vessels into the tissue. As part of their bactericidal effect, leukocytes are known to induce iodide organification by means of a myeloperoxidase. Therefore, retention of radioiodine in leukocytes in clotted blood and tissues may also explain various reports of false-positive uptake in sites of inflammation. [17] cOncLuSiOn DTC, which ordinarily behaves in an indolent manner, can have unusual metastatic presentations and patterns.
Increasing importance should be given to rare metastases in DTC patients. This pictorial review highlights the need to create an awareness to detect metastatic deposits of DTC at unexpected sites. Care should be taken to determine whether 131 I uptake found at an unexpected site is DTC metastasis or false-positive uptake.
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